Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.14B | $ 1.15B | $ 784.10M | $ 904.80M | $ 702.10M |
Total Assets | $ 4.64B | $ 4.60B | $ 4.35B | $ 4.63B | $ 6.73B |
Total Debt | $ 2.20B | $ 2.15B | $ 2.18B | $ 2.31B | $ 2.39B |
Net Debt | $ 1.06B | $ 998.90M | $ 1.39B | $ 1.41B | $ 1.69B |
Total Liabilities | $ 3.98B | $ 3.90B | $ 3.96B | $ 4.39B | $ 4.33B |
Stockholders Equity | $ 641.30M | $ 682.00M | $ 370.60M | $ 227.40M | $ 2.38B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |